Chemical context   {#sec1}
==================

The efficient synthesis of nagelamide alkaloids (a subfamily of oroidin natural products derived from marine sponges) has garnered inter­est (Du *et al.*, 2006[@bb4]; Das *et al.*, 2016[@bb3]) since first reported (Endo *et al.*, 2004[@bb5]). Allylic azides (Carlson & Top­czewski, 2019[@bb16]) are fairly reactive making them attractive starting compounds to convert into amides. Our group has successfully synthesized a number of azide-containing imidazole derivatives and determined their structures. Many of our strategies have led to the successful synthesis of several nagelamide derivatives (Bhandari *et al.*, 2009[@bb1]; Mukherjee *et al.*, 2010[@bb17]). However, the application of our approaches to several other nagelamide congeners were unsuccessful, leading us to rethink our tactics. Recently, we reported the efficient synthesis of amide compounds from allylic azide-containing imidazoles (Herath *et al.*, 2017[@bb8]). In that report we were also able to show that although the imidazoles contained di­methyl­amino­sulfonyl (DMAS) protecting groups, efficient conversion to amides was still possible. In addition, the free imidazole (lacking the protecting group but still containing azide) underwent selective and rapid conversion to amide without the undesired hydro­sulfenylation we observed with protected imidazoles. Here we present the crystal structures of two azide-containing imidazoles, 4-{(*E*)-3-\[(imino-λ^5^-aza­nyl­idene)amino\]­prop-1-en­yl}-*N*,*N*-di­methyl­imidazole-1-sulfonamide (**1**) and 2-\[(imino-λ^5^-aza­nyl­idene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-aza­nyl­idene)amino\]­prop-1-en­yl}-*N*,*N*-di­methyl­imidazole-1-sulfonamide (**2**). These compounds were synthesized in the previous study but the structures were not reported. Figs. 1[▸](#fig1){ref-type="fig"} and 2[▸](#fig2){ref-type="fig"} show displacement ellipsoid plots of **1** and **2**, respectively.

Structural commentary   {#sec2}
=======================

Compound **1** contains one allylic azide while compound **2** contains two azide groups, an allylic azide and one azide bound directly to the imidazole ring at C2. The azide group in **1** shows an N3---N4 distance of 1.229 (2) Å and an N4---N5 distance of 1.128 (2) Å. The N3---N4---N5 angle is 172.32 (13)°. The azide groups in **2** show an N3---N4 distance of 1.253 (2) Å, N4---N5 distance of 1.129 (2) Å, N6---N7 distance of 1.239 (2) Å, and N7---N8 distance of 1.134 (2) Å. The N3---N4---N5 angle is 171.58 (15)° and the N6---N7---N8 angle is 173.95 (15)°. All three azide moieties in both compounds show the same general trend of a longer N~α~---N~β~ distance and shorter N~β~---N~γ~ distance with a quasilinear geometry. This is typical for covalent azides with terminal N~β~---N~γ~ demonstrating more triple-bond character. A previously reported covalent azide occurring in the compound ethyl-2-\[(azido­carbon­yl)amino\]­benzoate demonstrated bond lengths N~α~---N~β~ of 1.264 (2) Å and N~β~---N~γ~ of 1.131 (2) Å and an N~α~---N~β~---N~α~ angle of 174.7 (2)° (Yassine *et al.*, 2016[@bb15]).

The torsion angles for the azides and dihedral angles between the azides and imidazole rings for both compounds have been measured. The allylic azide torsion angles between **1** and **2** are quite different. The measured torsion angle for the allylic azide (C5---C6---N3---N4) in **1** was −115.21 (13)° while the related torsion angle (C5---C6---N6---N7) in **2** was 50.25 (18)°. **2** contains one azide group bound to the imidazole at C2 and shows a torsion angle N1---C2---N3---N4 of −174.82 (11)°. The allylic azides in both compounds exhibit a similar dihedral angle between the azide and the imidazole ring, 70.3 (11)° for **1** and 77.3 (17)° for **2**. While the imidazole-bound azide in **2** shows a dihedral angle of 5.0 (10)°. Indeed, the torsion angle and dihedral angle for this particular azide demonstrate the near planarity between the imidazole and its covalently bound azide. Figs. 3[▸](#fig3){ref-type="fig"} and 4[▸](#fig4){ref-type="fig"} show the dihedral planes for **1** and **2**, respectively.

Both title compounds contain a DMAS protecting group. The amine component of this protecting group is *sp* ^3^-hybrid­ized, as validated by the C---N---C bond angles C6---N6---C8 = 113.86 (10)° for **1** and C7---N9---C8 = 113.93 (12)° for **2**. Both compounds also contain a double bond between C4 and C5. The measured bond distance is 1.333 (2) Å for **1** and 1.340 (2) Å for **2**.

The imidazole ring in **1** is substituted at the N1 and C3 position with no substitution at C2. The N1---C2 distance is 1.378 (2) Å while the N2---C2 distance is 1.301 (2) Å. However, in **2**, the imidazole ring is substituted with an azide group at C2 but this seemingly has no effect on the ring bond distances. The measured bond distances for N1---C2 and N2---C2 in **2** are 1.385 (2) and 1.310 (2) Å, respectively.

There is, however, a significant difference in the measured N1---S1 distance for the two compounds. The imidazole ring is substituted at the N1 position for both compounds with DMAS. The N1---S1 distance for **1** is 1.686 (1) Å and 1.718 (1) Å for **2**. The disparity may be attributed to the presence of azide, which is substituted at the C2 position for **2**.

Supra­molecular features   {#sec3}
==========================

The title compounds each contain bulky DMAS protecting groups and hydrogen bond distances that influence the mol­ecule packing. Compound **1** shows C1---H1⋯O1^i^ and C2---H2⋯O2^ii^ inter­actions of 2.53 and 2.39 Å, respectively. There is also a C4---H4⋯N5^iii^ inter­action of 2.70 Å (symmetry codes as in Table 1[▸](#table1){ref-type="table"}). Compound **2** demonstrates a C7---H7*B*⋯O1^i^ inter­action of 2.51 Å. There are also C6---H6*A*⋯N8^ii^ and C7---H7*C*⋯N6^iii^ inter­actions of 2.70 and 2.62 Å, respectively (symmetry codes as in Table 2[▸](#table2){ref-type="table"}). Figs. 5[▸](#fig5){ref-type="fig"} and 6[▸](#fig6){ref-type="fig"} show the close contacts for **1** and **2**, respectively.

Although both compounds contain aromatic rings, there appears to be no π-stacking present in the crystals of either compound. The stacking appears more staggered, most likely due to the presence of bulky DMAS groups on both compounds. However, the staggering in **1** appears more pronounced than in **2**. In other words, the mol­ecules are further apart in **1**. This is most likely due to the larger torsion angle for the azide in **1** than in **2**.

Database survey   {#sec4}
=================

A search of related compounds was conducted in the Cambridge Structural Database (Version 5.38; Groom *et al.*, 2016[@bb6]). One very closely related compound, methyl 3-(1-(di­methyl­sulfamo­yl)-1*H*-imidazol-5-yl)acrylate, was reported (Lovely *et al.*, 2010[@bb9]). This particular compound contains an imidazole with a DMAS protecting group and an allylic ester moiety. The DMAS amine has a C---N---C angle of 114.33 (14)°, showing the same amine hybridization exhibited in **1** and **2**. The C4=C5 double bond distance is measured to be 1.330 (2) Å which is similar to the bond distances in **1** and **2** \[1.333 (2) and 1.340 (2) Å respectively\].

The crystal structure of a related allylic azide has been reported from our previous study (Herath *et al.*, 2017[@bb8]). This particular compound is a dimerized mol­ecule with two allylic azides.

Synthesis and crystallization   {#sec5}
===============================

The syntheses of the title compounds were previously reported by our group (Lovely *et al.*, 2017[@bb9]). As shown in Fig. 7[▸](#fig7){ref-type="fig"}, the parent allylic azide **1** was prepared from the known alcohol starting compound (He *et al.*, 2003[@bb7]) by treatment with di­phenyl­phospho­rylazide (DPPA) and 1,8-di­aza­bicyclo­\[5.4.0\]undec-7-ene (DBU) according to the procedure described previously (Thompson *et al.*, 1993[@bb14]). Crystals were acquired by dissolving title compounds in ethanol with heating and slowly cooling in a freezer. Crystals appeared after about 1 week.

Refinement   {#sec6}
============

Crystal data, data collection and structure refinement details for **1** and **2** are summarized in Table 3[▸](#table3){ref-type="table"}. Refinement for both compounds were routine. H atoms were positioned geometrically (C---H = 0.95--0.98 Å) and allowed to ride on their parent atoms, with *U* ~iso~(H) = 1.5*U* ~eq~(C) for methyl H and 1.2*U* ~eq~(C) for other H atoms.

Supplementary Material
======================

Crystal structure: contains datablock(s) compound_1, compound_2. DOI: [10.1107/S205698901900519X/zl2753sup1.cif](https://doi.org/10.1107/S205698901900519X/zl2753sup1.cif)

Structure factors: contains datablock(s) compound_1. DOI: [10.1107/S205698901900519X/zl2753compound_1sup2.hkl](https://doi.org/10.1107/S205698901900519X/zl2753compound_1sup2.hkl)

Structure factors: contains datablock(s) compound_2. DOI: [10.1107/S205698901900519X/zl2753compound_2sup3.hkl](https://doi.org/10.1107/S205698901900519X/zl2753compound_2sup3.hkl)

###### 

Click here for additional data file.

Supporting information file. DOI: [10.1107/S205698901900519X/zl2753compound_1sup4.cml](https://doi.org/10.1107/S205698901900519X/zl2753compound_1sup4.cml)

###### 

Click here for additional data file.

Supporting information file. DOI: [10.1107/S205698901900519X/zl2753compound_2sup5.cml](https://doi.org/10.1107/S205698901900519X/zl2753compound_2sup5.cml)

CCDC references: [1910313](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1910313), [1910312](http://scripts.iucr.org/cgi-bin/cr.cgi?rm=csd&csdid=1910312)

Additional supporting information: [crystallographic information](http://scripts.iucr.org/cgi-bin/sendsupfiles?zl2753&file=zl2753sup0.html&mime=text/html); [3D view](http://scripts.iucr.org/cgi-bin/sendcif?zl2753sup1&Qmime=cif); [checkCIF report](http://scripts.iucr.org/cgi-bin/paper?zl2753&checkcif=yes)

The authors thank the Center for Nanostructured Materials at the University of Texas at Arlington for the use of their diffractometer.

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Crystal data {#d1e163}
===========================================================================================================================

  ---------------------- ---------------------------------------
  C~8~H~12~N~6~O~2~S     *Z* = 2
  *M~r~* = 256.30        *F*(000) = 268
  Triclinic, *P*1        *D*~x~ = 1.512 Mg m^−3^
  *a* = 5.4252 (15) Å    Mo *K*α radiation, λ = 0.71073 Å
  *b* = 9.830 (3) Å      Cell parameters from 4940 reflections
  *c* = 11.137 (3) Å     θ = 3.2--33.3°
  α = 74.636 (5)°        µ = 0.29 mm^−1^
  β = 83.418 (5)°        *T* = 100 K
  γ = 80.255 (5)°        Prism, colourless
  *V* = 563.0 (3) Å^3^   0.25 × 0.20 × 0.05 mm
  ---------------------- ---------------------------------------

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Data collection {#d1e295}
==============================================================================================================================

  ---------------------------------------------------------- --------------------------------------
  Bruker D8 Quest diffractometer                             3477 reflections with *I* \> 2σ(*I*)
  φ and ω scans                                              *R*~int~ = 0.033
  Absorption correction: multi-scan (SADABS; Bruker, 2016)   θ~max~ = 33.4°, θ~min~ = 3.2°
  *T*~min~ = 0.616, *T*~max~ = 0.746                         *h* = −8→8
  9314 measured reflections                                  *k* = −15→15
  4292 independent reflections                               *l* = −17→17
  ---------------------------------------------------------- --------------------------------------

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Refinement {#d1e404}
=========================================================================================================================

  ---------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Refinement on *F*^2^                                             Hydrogen site location: inferred from neighbouring sites
  Least-squares matrix: full                                       H-atom parameters constrained
  *R*\[*F*^2^ \> 2σ(*F*^2^)\] = 0.039                              *w* = 1/\[σ^2^(*F*~o~^2^) + (0.0486*P*)^2^ + 0.2224*P*\] where *P* = (*F*~o~^2^ + 2*F*~c~^2^)/3
  *wR*(*F*^2^) = 0.104                                             (Δ/σ)~max~ = 0.001
  *S* = 1.01                                                       Δρ~max~ = 0.42 e Å^−3^
  4292 reflections                                                 Δρ~min~ = −0.48 e Å^−3^
  157 parameters                                                   Extinction correction: SHELXL2017 (Sheldrick, 2015b), Fc^\*^=kFc\[1+0.001xFc^2^λ^3^/sin(2θ)\]^-1/4^
  0 restraints                                                     Extinction coefficient: 0.035 (6)
  Primary atom site location: structure-invariant direct methods   
  ---------------------------------------------------------------- -----------------------------------------------------------------------------------------------------

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Special details {#d1e579}
==============================================================================================================================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å^2^) {#d1e598}
=================================================================================================================================================================================================================

  ----- -------------- --------------- -------------- -------------------- --
        *x*            *y*             *z*            *U*~iso~\*/*U*~eq~   
  S1    1.02066 (5)    0.56887 (3)     0.72049 (3)    0.01267 (8)          
  O1    1.14077 (17)   0.54225 (11)    0.60703 (8)    0.01878 (19)         
  O2    1.15939 (17)   0.56915 (10)    0.82106 (8)    0.01797 (18)         
  N1    0.84664 (19)   0.43637 (11)    0.77979 (9)    0.01388 (19)         
  N2    0.6248 (2)     0.28893 (12)    0.91880 (10)   0.0177 (2)           
  N3    0.1658 (2)     −0.00361 (13)   0.71066 (11)   0.0199 (2)           
  N4    −0.0161 (2)    0.04337 (11)    0.64781 (10)   0.0164 (2)           
  N5    −0.1668 (2)    0.08138 (15)    0.57975 (11)   0.0256 (3)           
  N6    0.82889 (19)   0.71510 (11)    0.68919 (10)   0.01508 (19)         
  C1    0.7216 (2)     0.37309 (13)    0.71178 (11)   0.0140 (2)           
  H1    0.728564       0.389191        0.623584       0.017\*              
  C2    0.7775 (3)     0.38185 (14)    0.90406 (11)   0.0176 (2)           
  H2    0.834333       0.408815        0.970797       0.021\*              
  C3    0.5864 (2)     0.28275 (13)    0.79888 (11)   0.0139 (2)           
  C4    0.4234 (2)     0.19129 (12)    0.77555 (11)   0.0144 (2)           
  H4    0.407866       0.192306        0.691209       0.017\*              
  C5    0.2939 (2)     0.10591 (13)    0.86438 (11)   0.0160 (2)           
  H5    0.306699       0.106802        0.948514       0.019\*              
  C6    0.1298 (2)     0.00877 (14)    0.84143 (12)   0.0174 (2)           
  H6A   0.168435       −0.086933       0.898507       0.021\*              
  H6B   −0.047919      0.045775        0.860031       0.021\*              
  C7    0.6774 (3)     0.73822 (15)    0.58222 (13)   0.0211 (3)           
  H7A   0.536984       0.683286        0.607359       0.032\*              
  H7B   0.781837       0.706956        0.513923       0.032\*              
  H7C   0.612380       0.839831        0.554136       0.032\*              
  C8    0.6881 (3)     0.75732 (15)    0.79801 (13)   0.0211 (3)           
  H8A   0.611434       0.857329        0.772839       0.032\*              
  H8B   0.802632       0.745666        0.863140       0.032\*              
  H8C   0.556684       0.697062        0.830419       0.032\*              
  ----- -------------- --------------- -------------- -------------------- --

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Atomic displacement parameters (Å^2^) {#d1e994}
====================================================================================================================================================

  ---- -------------- -------------- -------------- -------------- -------------- ---------------
       *U*^11^        *U*^22^        *U*^33^        *U*^12^        *U*^13^        *U*^23^
  S1   0.01100 (13)   0.01655 (14)   0.01073 (13)   −0.00187 (9)   −0.00111 (9)   −0.00383 (10)
  O1   0.0157 (4)     0.0266 (5)     0.0153 (4)     −0.0035 (3)    0.0026 (3)     −0.0087 (4)
  O2   0.0151 (4)     0.0247 (5)     0.0155 (4)     −0.0014 (3)    −0.0055 (3)    −0.0066 (3)
  N1   0.0176 (5)     0.0138 (4)     0.0102 (4)     −0.0028 (4)    −0.0014 (3)    −0.0025 (3)
  N2   0.0248 (5)     0.0166 (5)     0.0110 (4)     −0.0035 (4)    −0.0011 (4)    −0.0023 (4)
  N3   0.0150 (5)     0.0256 (6)     0.0204 (5)     −0.0007 (4)    −0.0020 (4)    −0.0091 (4)
  N4   0.0163 (5)     0.0170 (5)     0.0164 (5)     −0.0033 (4)    0.0022 (4)     −0.0057 (4)
  N5   0.0231 (6)     0.0337 (7)     0.0202 (5)     0.0032 (5)     −0.0023 (4)    −0.0113 (5)
  N6   0.0145 (4)     0.0154 (5)     0.0145 (4)     −0.0021 (4)    −0.0026 (4)    −0.0017 (4)
  C1   0.0164 (5)     0.0154 (5)     0.0107 (5)     −0.0019 (4)    −0.0014 (4)    −0.0040 (4)
  C2   0.0251 (6)     0.0176 (5)     0.0104 (5)     −0.0040 (5)    −0.0021 (4)    −0.0028 (4)
  C3   0.0165 (5)     0.0133 (5)     0.0112 (5)     −0.0003 (4)    −0.0009 (4)    −0.0029 (4)
  C4   0.0151 (5)     0.0145 (5)     0.0127 (5)     −0.0005 (4)    −0.0012 (4)    −0.0027 (4)
  C5   0.0171 (5)     0.0174 (5)     0.0129 (5)     −0.0014 (4)    −0.0012 (4)    −0.0032 (4)
  C6   0.0166 (5)     0.0190 (5)     0.0154 (5)     −0.0035 (4)    −0.0003 (4)    −0.0020 (4)
  C7   0.0201 (6)     0.0213 (6)     0.0200 (6)     −0.0045 (5)    −0.0075 (5)    0.0014 (5)
  C8   0.0207 (6)     0.0191 (6)     0.0231 (6)     0.0008 (5)     0.0013 (5)     −0.0079 (5)
  ---- -------------- -------------- -------------- -------------- -------------- ---------------

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Geometric parameters (Å, º) {#d1e1386}
==========================================================================================================================================

  -------------- ------------- ---------------- -------------
  S1---O2        1.4200 (9)    C2---H2          0.9500
  S1---O1        1.4209 (10)   C3---C4          1.4505 (17)
  S1---N6        1.6067 (11)   C4---C5          1.3332 (17)
  S1---N1        1.6858 (11)   C4---H4          0.9500
  N1---C2        1.3783 (15)   C5---C6          1.4963 (18)
  N1---C1        1.3896 (15)   C5---H5          0.9500
  N2---C2        1.3012 (17)   C6---H6A         0.9900
  N2---C3        1.3934 (15)   C6---H6B         0.9900
  N3---N4        1.2288 (15)   C7---H7A         0.9800
  N3---C6        1.4814 (17)   C7---H7B         0.9800
  N4---N5        1.1277 (16)   C7---H7C         0.9800
  N6---C7        1.4711 (16)   C8---H8A         0.9800
  N6---C8        1.4736 (17)   C8---H8B         0.9800
  C1---C3        1.3668 (16)   C8---H8C         0.9800
  C1---H1        0.9500                         
                                                
  O2---S1---O1   121.78 (6)    C5---C4---C3     124.48 (11)
  O2---S1---N6   108.51 (6)    C5---C4---H4     117.8
  O1---S1---N6   108.95 (6)    C3---C4---H4     117.8
  O2---S1---N1   104.30 (6)    C4---C5---C6     124.87 (11)
  O1---S1---N1   105.35 (5)    C4---C5---H5     117.6
  N6---S1---N1   106.96 (6)    C6---C5---H5     117.6
  C2---N1---C1   106.84 (10)   N3---C6---C5     111.73 (10)
  C2---N1---S1   126.59 (9)    N3---C6---H6A    109.3
  C1---N1---S1   126.18 (8)    C5---C6---H6A    109.3
  C2---N2---C3   105.77 (10)   N3---C6---H6B    109.3
  N4---N3---C6   116.05 (11)   C5---C6---H6B    109.3
  N5---N4---N3   172.32 (13)   H6A---C6---H6B   107.9
  C7---N6---C8   113.86 (10)   N6---C7---H7A    109.5
  C7---N6---S1   116.58 (9)    N6---C7---H7B    109.5
  C8---N6---S1   115.49 (9)    H7A---C7---H7B   109.5
  C3---C1---N1   105.29 (10)   N6---C7---H7C    109.5
  C3---C1---H1   127.4         H7A---C7---H7C   109.5
  N1---C1---H1   127.4         H7B---C7---H7C   109.5
  N2---C2---N1   111.73 (11)   N6---C8---H8A    109.5
  N2---C2---H2   124.1         N6---C8---H8B    109.5
  N1---C2---H2   124.1         H8A---C8---H8B   109.5
  C1---C3---N2   110.36 (11)   N6---C8---H8C    109.5
  C1---C3---C4   127.00 (11)   H8A---C8---H8C   109.5
  N2---C3---C4   122.65 (11)   H8B---C8---H8C   109.5
  -------------- ------------- ---------------- -------------

4-{(*E*)-3-\[(Imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_1). Hydrogen-bond geometry (Å, º) {#d1e1760}
============================================================================================================================================

  ------------------- --------- --------- ------------- ---------------
  *D*---H···*A*       *D*---H   H···*A*   *D*···*A*     *D*---H···*A*
  C1---H1···O1^i^     0.95      2.53      3.4487 (18)   164
  C2---H2···O2^ii^    0.95      2.39      3.2861 (18)   157
  C4---H4···N5^iii^   0.95      2.70      3.1920 (17)   113
  ------------------- --------- --------- ------------- ---------------

Symmetry codes: (i) −*x*+2, −*y*+1, −*z*+1; (ii) −*x*+2, −*y*+1, −*z*+2; (iii) *x*+1, *y*, *z*.

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Crystal data {#d1e1921}
===============================================================================================================================================================

  ---------------------- ---------------------------------------
  C~8~H~11~N~9~O~2~S     *Z* = 2
  *M~r~* = 297.32        *F*(000) = 308
  Triclinic, *P*1        *D*~x~ = 1.495 Mg m^−3^
  *a* = 6.6151 (18) Å    Mo *K*α radiation, λ = 0.71073 Å
  *b* = 9.563 (3) Å      Cell parameters from 5257 reflections
  *c* = 11.634 (3) Å     θ = 3.2--33.6°
  α = 108.645 (4)°       µ = 0.26 mm^−1^
  β = 105.994 (4)°       *T* = 100 K
  γ = 93.828 (4)°        Needle, colourless
  *V* = 660.6 (3) Å^3^   0.80 × 0.28 × 0.08 mm
  ---------------------- ---------------------------------------

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Data collection {#d1e2053}
==================================================================================================================================================================

  ---------------------------------------------------------- --------------------------------------
  Bruker D8 Quest diffractometer                             4051 reflections with *I* \> 2σ(*I*)
  φ and ω scans                                              *R*~int~ = 0.030
  Absorption correction: multi-scan (SADABS; Bruker, 2016)   θ~max~ = 33.7°, θ~min~ = 3.2°
  *T*~min~ = 0.634, *T*~max~ = 0.747                         *h* = −10→10
  11030 measured reflections                                 *k* = −14→14
  5171 independent reflections                               *l* = −17→18
  ---------------------------------------------------------- --------------------------------------

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Refinement {#d1e2162}
=============================================================================================================================================================

  ---------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Refinement on *F*^2^                                             Hydrogen site location: inferred from neighbouring sites
  Least-squares matrix: full                                       H-atom parameters constrained
  *R*\[*F*^2^ \> 2σ(*F*^2^)\] = 0.043                              *w* = 1/\[σ^2^(*F*~o~^2^) + (0.0401*P*)^2^ + 0.3565*P*\] where *P* = (*F*~o~^2^ + 2*F*~c~^2^)/3
  *wR*(*F*^2^) = 0.109                                             (Δ/σ)~max~ \< 0.001
  *S* = 1.07                                                       Δρ~max~ = 0.46 e Å^−3^
  5171 reflections                                                 Δρ~min~ = −0.60 e Å^−3^
  184 parameters                                                   Extinction correction: SHELXL2017 (Sheldrick, 2015b), Fc^\*^=kFc\[1+0.001xFc^2^λ^3^/sin(2θ)\]^-1/4^
  0 restraints                                                     Extinction coefficient: 0.022 (3)
  Primary atom site location: structure-invariant direct methods   
  ---------------------------------------------------------------- -----------------------------------------------------------------------------------------------------

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Special details {#d1e2337}
==================================================================================================================================================================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å^2^) {#d1e2356}
=====================================================================================================================================================================================================================================================

  ----- -------------- -------------- -------------- -------------------- --
        *x*            *y*            *z*            *U*~iso~\*/*U*~eq~   
  S1    0.58817 (5)    0.32361 (4)    0.11881 (3)    0.01478 (8)          
  O1    0.65163 (17)   0.18829 (12)   0.05384 (10)   0.0219 (2)           
  O2    0.66446 (17)   0.46415 (12)   0.11471 (10)   0.0215 (2)           
  N1    0.68124 (18)   0.33810 (13)   0.27604 (10)   0.0146 (2)           
  N2    0.75962 (17)   0.42326 (13)   0.48977 (10)   0.0144 (2)           
  N3    0.64496 (19)   0.59233 (13)   0.37520 (11)   0.0174 (2)           
  N4    0.67946 (18)   0.69635 (13)   0.48007 (11)   0.0164 (2)           
  N5    0.7040 (2)     0.80092 (15)   0.56596 (13)   0.0242 (3)           
  N6    0.8624 (2)     0.18310 (17)   0.83285 (12)   0.0237 (3)           
  N7    0.66897 (19)   0.15149 (14)   0.77329 (12)   0.0193 (2)           
  N8    0.4889 (2)     0.12679 (17)   0.72893 (15)   0.0287 (3)           
  N9    0.33102 (18)   0.29742 (13)   0.07962 (11)   0.0156 (2)           
  C1    0.7358 (2)     0.21797 (15)   0.31603 (13)   0.0156 (2)           
  H1    0.738643       0.119381       0.263572       0.019\*              
  C2    0.69706 (19)   0.45659 (15)   0.38610 (12)   0.0139 (2)           
  C3    0.78417 (19)   0.27227 (15)   0.44638 (12)   0.0144 (2)           
  C4    0.8525 (2)     0.19077 (15)   0.53300 (12)   0.0156 (2)           
  H4    0.836577       0.084831       0.497346       0.019\*              
  C5    0.9364 (2)     0.25679 (16)   0.66005 (13)   0.0159 (2)           
  H5    0.954749       0.362879       0.695491       0.019\*              
  C6    1.0028 (2)     0.17314 (17)   0.74931 (13)   0.0181 (3)           
  H6A   1.152396       0.214636       0.803867       0.022\*              
  H6B   0.996255       0.066642       0.699097       0.022\*              
  C7    0.2306 (2)     0.15853 (17)   0.08670 (15)   0.0221 (3)           
  H7A   0.250179       0.171110       0.176261       0.033\*              
  H7B   0.297367       0.074636       0.048982       0.033\*              
  H7C   0.077775       0.137969       0.039540       0.033\*              
  C8    0.2288 (2)     0.42873 (17)   0.12339 (15)   0.0221 (3)           
  H8A   0.079649       0.408488       0.069371       0.033\*              
  H8B   0.304630       0.516510       0.117531       0.033\*              
  H8C   0.234224       0.448176       0.212252       0.033\*              
  ----- -------------- -------------- -------------- -------------------- --

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Atomic displacement parameters (Å^2^) {#d1e2766}
========================================================================================================================================================================================

  ---- -------------- -------------- -------------- -------------- -------------- --------------
       *U*^11^        *U*^22^        *U*^33^        *U*^12^        *U*^13^        *U*^23^
  S1   0.01499 (14)   0.01799 (16)   0.01287 (14)   0.00388 (11)   0.00554 (11)   0.00623 (11)
  O1   0.0251 (5)     0.0260 (5)     0.0168 (5)     0.0108 (4)     0.0107 (4)     0.0057 (4)
  O2   0.0222 (5)     0.0242 (5)     0.0211 (5)     −0.0001 (4)    0.0076 (4)     0.0122 (4)
  N1   0.0157 (5)     0.0157 (5)     0.0123 (4)     0.0037 (4)     0.0040 (4)     0.0049 (4)
  N2   0.0120 (4)     0.0159 (5)     0.0151 (5)     0.0010 (4)     0.0043 (4)     0.0055 (4)
  N3   0.0198 (5)     0.0148 (5)     0.0169 (5)     0.0027 (4)     0.0053 (4)     0.0052 (4)
  N4   0.0130 (5)     0.0164 (5)     0.0206 (5)     0.0021 (4)     0.0064 (4)     0.0066 (4)
  N5   0.0221 (6)     0.0208 (6)     0.0261 (6)     0.0026 (5)     0.0090 (5)     0.0025 (5)
  N6   0.0176 (5)     0.0379 (7)     0.0179 (5)     0.0039 (5)     0.0057 (4)     0.0129 (5)
  N7   0.0188 (5)     0.0212 (6)     0.0225 (6)     0.0048 (4)     0.0100 (4)     0.0105 (5)
  N8   0.0185 (6)     0.0307 (7)     0.0381 (8)     0.0026 (5)     0.0097 (5)     0.0134 (6)
  N9   0.0139 (5)     0.0152 (5)     0.0169 (5)     0.0026 (4)     0.0030 (4)     0.0060 (4)
  C1   0.0154 (5)     0.0160 (6)     0.0160 (5)     0.0034 (4)     0.0047 (4)     0.0063 (5)
  C2   0.0106 (5)     0.0148 (5)     0.0159 (5)     0.0004 (4)     0.0044 (4)     0.0051 (4)
  C3   0.0107 (5)     0.0169 (6)     0.0156 (5)     0.0015 (4)     0.0037 (4)     0.0063 (5)
  C4   0.0131 (5)     0.0178 (6)     0.0168 (6)     0.0032 (4)     0.0044 (4)     0.0076 (5)
  C5   0.0132 (5)     0.0193 (6)     0.0167 (6)     0.0031 (4)     0.0053 (4)     0.0078 (5)
  C6   0.0141 (5)     0.0254 (7)     0.0167 (6)     0.0050 (5)     0.0051 (4)     0.0093 (5)
  C7   0.0192 (6)     0.0195 (7)     0.0245 (7)     −0.0017 (5)    0.0028 (5)     0.0080 (5)
  C8   0.0180 (6)     0.0203 (7)     0.0251 (7)     0.0074 (5)     0.0042 (5)     0.0057 (5)
  ---- -------------- -------------- -------------- -------------- -------------- --------------

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Geometric parameters (Å, º) {#d1e3117}
==============================================================================================================================================================================

  -------------- ------------- ---------------- -------------
  S1---O2        1.4237 (11)   C1---C3          1.3707 (18)
  S1---O1        1.4297 (11)   C1---H1          0.9500
  S1---N9        1.6146 (12)   C3---C4          1.4579 (18)
  S1---N1        1.7177 (12)   C4---C5          1.3402 (19)
  N1---C2        1.3846 (17)   C4---H4          0.9500
  N1---C1        1.4039 (17)   C5---C6          1.4961 (19)
  N2---C2        1.3099 (17)   C5---H5          0.9500
  N2---C3        1.4058 (18)   C6---H6A         0.9900
  N3---N4        1.2531 (16)   C6---H6B         0.9900
  N3---C2        1.4002 (18)   C7---H7A         0.9800
  N4---N5        1.1291 (17)   C7---H7B         0.9800
  N6---N7        1.2389 (17)   C7---H7C         0.9800
  N6---C6        1.5053 (18)   C8---H8A         0.9800
  N7---N8        1.1342 (18)   C8---H8B         0.9800
  N9---C8        1.4792 (18)   C8---H8C         0.9800
  N9---C7        1.4814 (19)                    
                                                
  O2---S1---O1   121.70 (7)    N2---C3---C4     122.43 (12)
  O2---S1---N9   109.81 (6)    C5---C4---C3     123.73 (13)
  O1---S1---N9   108.59 (6)    C5---C4---H4     118.1
  O2---S1---N1   106.16 (6)    C3---C4---H4     118.1
  O1---S1---N1   102.88 (6)    C4---C5---C6     123.82 (13)
  N9---S1---N1   106.52 (6)    C4---C5---H5     118.1
  C2---N1---C1   105.71 (11)   C6---C5---H5     118.1
  C2---N1---S1   129.94 (10)   C5---C6---N6     111.84 (11)
  C1---N1---S1   124.00 (9)    C5---C6---H6A    109.2
  C2---N2---C3   104.81 (11)   N6---C6---H6A    109.2
  N4---N3---C2   114.19 (12)   C5---C6---H6B    109.2
  N5---N4---N3   171.58 (15)   N6---C6---H6B    109.2
  N7---N6---C6   113.91 (12)   H6A---C6---H6B   107.9
  N8---N7---N6   173.95 (15)   N9---C7---H7A    109.5
  C8---N9---C7   113.93 (12)   N9---C7---H7B    109.5
  C8---N9---S1   117.77 (10)   H7A---C7---H7B   109.5
  C7---N9---S1   115.55 (9)    N9---C7---H7C    109.5
  C3---C1---N1   105.82 (11)   H7A---C7---H7C   109.5
  C3---C1---H1   127.1         H7B---C7---H7C   109.5
  N1---C1---H1   127.1         N9---C8---H8A    109.5
  N2---C2---N1   113.05 (12)   N9---C8---H8B    109.5
  N2---C2---N3   128.30 (12)   H8A---C8---H8B   109.5
  N1---C2---N3   118.64 (11)   N9---C8---H8C    109.5
  C1---C3---N2   110.59 (11)   H8A---C8---H8C   109.5
  C1---C3---C4   126.98 (13)   H8B---C8---H8C   109.5
  -------------- ------------- ---------------- -------------

2-\[(Imino-λ^5^-azanylidene)amino\]-4-{(*E*)-3-\[(imino-λ^5^-azanylidene)amino\]prop-1-enyl}-*N*,*N*-dimethylimidazole-1-sulfonamide (compound_2). Hydrogen-bond geometry (Å, º) {#d1e3509}
================================================================================================================================================================================

  ---------------------- --------- --------- ----------- ---------------
  *D*---H···*A*          *D*---H   H···*A*   *D*···*A*   *D*---H···*A*
  C7---H7*B*···O1^i^     0.98      2.51      3.444 (2)   160
  C6---H6*A*···N8^ii^    0.99      2.70      3.337 (2)   123
  C7---H7*C*···N6^iii^   0.98      2.62      3.357 (2)   132
  ---------------------- --------- --------- ----------- ---------------

Symmetry codes: (i) −*x*+1, −*y*, −*z*; (ii) *x*+1, *y*, *z*; (iii) *x*−1, *y*, *z*−1.

![The mol­ecular structure of compound **1**, with atom labels and 50% probability displacement ellipsoids for non-H atoms.](e-75-00695-fig1){#fig1}

![The mol­ecular structure of compound **2**, with atom labels and 50% probability displacement ellipsoids for non-H atoms.](e-75-00695-fig2){#fig2}

![Dihedral planes between imidazole and allylic azide for compound **1**](e-75-00695-fig3){#fig3}

![Dihedral planes between imidazole and allylic azide for compound **2**](e-75-00695-fig4){#fig4}

![Close contacts for compound **1**.](e-75-00695-fig5){#fig5}

![Close contacts for compound **2**.](e-75-00695-fig6){#fig6}

![Synthetic scheme for both compounds. The title compounds are highlighted in red.](e-75-00695-fig7){#fig7}

###### Hydrogen-bond geometry (Å, °) for **1** [](#scheme1){ref-type="chem"}

  *D*---H⋯*A*       *D*---H   H⋯*A*   *D*⋯*A*       *D*---H⋯*A*
  ----------------- --------- ------- ------------- -------------
  C1---H1⋯O1^i^     0.95      2.53    3.4487 (18)   164
  C2---H2⋯O2^ii^    0.95      2.39    3.2861 (18)   157
  C4---H4⋯N5^iii^   0.95      2.70    3.1920 (17)   113

Symmetry codes: (i) ; (ii) ; (iii) .

###### Hydrogen-bond geometry (Å, °) for **2** [](#scheme1){ref-type="chem"}

  *D*---H⋯*A*          *D*---H   H⋯*A*   *D*⋯*A*     *D*---H⋯*A*
  -------------------- --------- ------- ----------- -------------
  C7---H7*B*⋯O1^i^     0.98      2.51    3.444 (2)   160
  C6---H6*A*⋯N8^ii^    0.99      2.70    3.337 (2)   123
  C7---H7*C*⋯N6^iii^   0.98      2.62    3.357 (2)   132

Symmetry codes: (i) ; (ii) ; (iii) .

###### Experimental details

                                                                             **1**                                       **2**
  -------------------------------------------------------------------------- ------------------------------------------- -------------------------------------------
  Crystal data                                                                                                           
  Chemical formula                                                           C~8~H~12~N~6~O~2~S                          C~8~H~11~N~9~O~2~S
  *M* ~r~                                                                    256.30                                      297.32
  Crystal system, space group                                                Triclinic, *P*                              Triclinic, *P*
  Temperature (K)                                                            100                                         100
  *a*, *b*, *c* (Å)                                                          5.4252 (15), 9.830 (3), 11.137 (3)          6.6151 (18), 9.563 (3), 11.634 (3)
  α, β, γ (°)                                                                74.636 (5), 83.418 (5), 80.255 (5)          108.645 (4), 105.994 (4), 93.828 (4)
  *V* (Å^3^)                                                                 563.0 (3)                                   660.6 (3)
  *Z*                                                                        2                                           2
  Radiation type                                                             Mo *K*α                                     Mo *K*α
  μ (mm^−1^)                                                                 0.29                                        0.26
  Crystal size (mm)                                                          0.25 × 0.20 × 0.05                          0.80 × 0.28 × 0.08
                                                                                                                         
  Data collection                                                                                                        
  Diffractometer                                                             Bruker D8 Quest                             Bruker D8 Quest
  Absorption correction                                                      Multi-scan (*SADABS*; Bruker, 2016[@bb2])   Multi-scan (*SADABS*; Bruker, 2016[@bb2])
  *T* ~min~, *T* ~max~                                                       0.616, 0.746                                0.634, 0.747
  No. of measured, independent and observed \[*I* \> 2σ(*I*)\] reflections   9314, 4292, 3477                            11030, 5171, 4051
  *R* ~int~                                                                  0.033                                       0.030
  (sin θ/λ)~max~ (Å^−1^)                                                     0.774                                       0.780
                                                                                                                         
  Refinement                                                                                                             
  *R*\[*F* ^2^ \> 2σ(*F* ^2^)\], *wR*(*F* ^2^), *S*                          0.039, 0.104, 1.01                          0.043, 0.109, 1.07
  No. of reflections                                                         4292                                        5171
  No. of parameters                                                          157                                         184
  H-atom treatment                                                           H-atom parameters constrained               H-atom parameters constrained
  Δρ~max~, Δρ~min~ (e Å^−3^)                                                 0.42, −0.48                                 0.46, −0.60

Computer programs: *APEX3* and *SAINT* (Bruker, 2016[@bb2]), *SHELXT2014* (Sheldrick, 2015*a* [@bb12]), *SHELXL2017* (Sheldrick, 2015*b* [@bb13]), *Mercury* (Macrae *et al.*, 2008[@bb10]) and *SHELXTL* (Sheldrick, 2008[@bb11]).
